Preventing acute liver injury via hepatocyte‐targeting nano‐antioxidants
Cell Proliferation · 2023-12 · 56 (12)
DOI: 10.1111/cpr.13494 ↗At a glance
Journal article in Cell Proliferation, published online on 2023-05-04. Written by Xuejiao Yuan and 7 co-authors. Institution: College of Chemistry and Materials Science, The Education Ministry Key Lab of Resource Chemistry, Joint International Research Laboratory of Resource…. Major MEDLINE topics: Antioxidants, Glycyrrhetinic Acid. Cited 33 times so far (Crossref); 48 references. The full text is freely available (open access, CC BY 4.0). Funded by: Major Science and Technology Innovation Program of Shanghai Municipal Education Commission, National Key R&D Program of China, National Natural Science Foundation of China.
Abstract (original language)
Acute liver injury (ALI) is a severe liver disease that is characterized by sudden and massive hepatocyte necrosis and deterioration of liver functions. Oxidative stress is increasingly recognized as a key factor in the induction and progression of ALI. Scavenging excessive reactive oxygen species (ROS) with antioxidants has become a promising therapeutic option, but intrinsically hepatocyte‐targeting antioxidants with excellent bioavailability and biocompatibility are yet to be developed. Herein, self‐assembling nanoparticles (NPs) composed of amphiphilic polymers are introduced to encapsulate organic Selenium compound L‐Se‐methylselenocysteine (SeMC) and form SeMC NPs, which protect the viabilities and functions of cultured hepatocytes in drug‐ or chemical‐induced acute hepatotoxicity models via efficient ROS removal. After further functionalization with the hepatocyte‐targeting ligand glycyrrhetinic acid (GA), the resultant GA‐SeMC NPs exhibit enhanced hepatocyte uptake and liver accumulation. In mouse models of ALI induced by acetaminophen (APAP) or carbon tetrachloride (CCl 4 ), treatment with GA‐SeMC NPs significantly decrease the levels of hepatic lipid peroxidation, tissue vacuolization and serum liver transaminases, while prominently increase that of endogenous antioxidant enzymes. Our study therefore presents a liver‐targeting drug delivery strategy for the prevention and treatment of hepatic diseases.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- College of Chemistry and Materials Science, The Education Ministry Key Lab of Resource Chemistry, Joint International Research Laboratory of Resource Chemistry of Ministry of Education, Shanghai Key Laboratory of Rare E…
- School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- He'nan Xibaikang Health Industry Co., Ltd, Jiyuan, China.
- Department of Neurology, Xuhui District Central Hospital, Shanghai, China.
ORCID profiles: Yanfeng Zhou, Nan Chen
Funding
- Major Science and Technology Innovation Program of Shanghai Municipal Education Commission
- National Key R&D Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai
- Shanghai Sailing Program
- National Key Research and Development Program of China
- Natural Science Foundation of Shanghai Municipality
Cite
APA
Yuan, X., Zhou, Y., Sun, J., Wang, S., Hu, X., Li, J., Huang, J., & Chen, N. (2023). Preventing acute liver injury via hepatocyte‐targeting nano‐antioxidants. Cell Proliferation, 56(12). https://doi.org/10.1111/cpr.13494
Vancouver
Yuan X, Zhou Y, Sun J, Wang S, Hu X, Li J, et al. Preventing acute liver injury via hepatocyte‐targeting nano‐antioxidants. Cell Proliferation. 2023;56(12). doi:10.1111/cpr.13494
BibTeX
@article{Yuan2023,
author = {Yuan, Xuejiao and Zhou, Yanfeng and Sun, Jinli and Wang, Shanshan and Hu, Xingjie and Li, Jiyu and Huang, Jing and Chen, Nan},
title = {Preventing acute liver injury via hepatocyte‐targeting nano‐antioxidants},
journal = {Cell Proliferation},
year = {2023},
volume = {56},
number = {12},
doi = {10.1111/cpr.13494}
}
EUVIMED